Plain-English translation of NCT07071519 on ClinicalTrials.gov ↗ ·
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a medication that helps reduce inflammation in the colon and rectum caused by ulcerative colitis. Researchers want to see how well this medication works in children and teenagers whose ulcerative colitis hasn't responded well to other treatments. The study will also measure how safe the medication is and how your body processes it.
Ulcerative colitis causes painful bleeding and inflammation in the large intestine, and some children don't improve with currently available treatments. This trial is testing whether this medication could be a safer and more effective option for young patients who need better control of their symptoms.
You likely qualify if…
You likely don't qualify if…
You would visit a hospital or clinic regularly over about 14 months. First, you'd receive the medication by IV injection for 12 weeks to see if it helps your symptoms. Then, if you improve, you'd be randomly assigned to receive either a lower or higher dose of the medication as an injection under the skin for one year. Throughout the study, you'd have blood tests and check-ups to make sure the treatment is working and to watch for side effects.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States